EDIT Stock Price
Editas Medicine, Inc.
EDIT stock price is $2.84 (+3.27% on the day), giving Editas Medicine, Inc. a market cap of $422.35M. Below are the price chart, the MarketXLS Rank, the company profile and the latest news.
EDIT Stock Overview
- Price
- $2.84
- Previous close
- $2.75
- Open
- $2.79
- Market cap
- $422.35M
- P/E ratio
- -2.6
- 52-week range
- $1.66 - $4.54
- 1-year price target
- $5.68
- Sector
- Healthcare
- Industry
- Biotechnology
- Exchange
- NGS
- MarketXLS Rank
- 46
About Editas Medicine, Inc.
Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. The company develops a proprietary gene editing platform based on CRISPR technology. It has a research collaboration with Juno Therapeutics, Inc. to develop alpha-beta T-cell experimental medicines for the treatment of solid and liquid tumors. The company was formerly known as Gengine, Inc. and changed its name to Editas Medicine, Inc. in November 2013. Editas Medicine, Inc. was incorporated in 2013 and is based in Cambridge, Massachusetts.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | EDIT | $2.84 | +3.3% | 5.87M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |